Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma

Farmacia Hospitalaria - Tập 43 - Trang 187-193 - 2019
Leticia García-Mochón1,2,3,4, Manuel David Gil-Sierra5,6, Emilio Jesús Alegre-del Rey5, Catalina Alarcón de la Lastra-Romero6, Marina Sánchez-Hidalgo6
1Andalusian School of Public Health, Granada, Spain
2Biomedical Research Center at Ciber for Epidemiology and Public Health (CIBERESP by its Spanish acronym), Madrid. Spain
3IBS Biomedical Research Institute, Granada, Spain
4University Hospitals of Granada/University of Granada, Granada. Spain
5Pharmacy Service, Puerto Real University Hospital, Puerto Real. Spain
6Department of Pharmacology, School of Pharmacy, University of Seville, Seville, Spain

Thông tin
Thông tin xuất bản

Farmacia Hospitalaria

Tập 43

187-193

Thông tin tác giả